C-Reactive Protein and Cardiovascular Risk in the General Population: A European Heart Journal Study by Berkan Kurt et al.
Berkan Kurt, Resident Physician in Cardiology and Internal Medicine at Uniklinik RWTH Aachen, posted on LinkedIn:
“Deeply grateful to share that our article “C-reactive protein and cardiovascular risk in the general population” has now been published in the European Heart Journal.
In 448 653 adults without known ASCVD, a single hsCRP measurement showed strong stability over time, displayed long-term inflammatory risk, and independently predicted MACE, CV death and all-cause mortality across clinically relevant subgroups, including SMuRF-less but inflamed individuals. hsCRP ranked among the strongest predictors of CV outcomes and added incremental value to SCORE2-based risk prediction. 
Our findings underscore residual inflammatory risk as an additional, relevant dimension in primary prevention. Routine hsCRP assessment should be considered for inclusion in future guidelines to refine CV risk assessment and to improve prevention strategies in patients without a history of ASCVD.
Sincerely thankful to my mentor Florian Kahles for his continuous support and guidance, my colleague Martin Reugels for the outstanding work together on this project, and to all co-authors and international colleagues for their generous collaboration and the privilege of working together with leading experts in the field.
Open access article”
Title: C-reactive protein and cardiovascular risk in the general population
Authors: Berkan Kurt, Martin Reugels, Kai M Schneider, Jens Spiesshoefer, Andrea Milzi, Alexander Gombert, Christopher B Fordyce, Florian A Wenzl, Neha J Pagidipati, Viviane Rocha, Marat Fudim, Abhinav Sharma, Michael Lehrke, Hiroaki Shimokawa, Giovanna Liuzzo, Lale Tokgozoglu, Filippo Crea, Thomas F Lüscher, Peter Libby, Paul M Ridker, Nikolaus Marx, Carolin V Schneider, Florian Kahles
Get the latest from Hemostasis Today.
-
May 11, 2026, 01:38Heghine Khachatryan: The Emerging Era of Immunothrombosis and Precision Vascular Medicine
-
May 10, 2026, 18:07Recurrent DVT and PE in Young Adults May Indicate an Underlying Cause – The Lancet Group
-
May 10, 2026, 18:06Noemi Zampatti: Pediatric Celiac Crisis Complicated by Refeeding Syndrome and Proposed Diagnostic Criteria
-
May 10, 2026, 18:05Giovanni Solimeno: When the Common Femoral Artery Wall is Diseased, Closure is Not a Step
-
May 10, 2026, 18:04Maitri Vaishnav: The Bombay Blood Group and the Critical Role of the H Antigen
-
May 10, 2026, 18:03Nicolas Hubacz: Mesenchymal Stem Cells Are Some of the Most Fascinating Cells in Regenerative Medicine
-
May 10, 2026, 16:20Joshua Ngimbwa: How Sex and Socioeconomic Factors Influence Stroke Outcomes in Tanzania
-
May 10, 2026, 16:18Gustavo Monnerat: How Thousands of Fake References Slipped Into Biomedical Literature
-
May 10, 2026, 16:13Dalius Jatužis: Our AI-Driven Automated Stroke Registry Data Extraction Gets Best Poster Award at ESOC 2026